Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
4
×
national blog main
biotech
boston blog main
boston top stories
boston
clinical trials
national top stories
san francisco blog main
aldehyde
aldeyra therapeutics
allergic conjunctivitis
black diamond therapeutics
bladder cancer
blueprint medicines
brexanalone
cancer
cancer drugs
clinical data
clinical study
data
deciphera pharmaceuticals
depression
disease
drugs
dry eye disease
eli lilly
endometral cancer
enzyme
europe blog main
european society for medical oncology
fda
gag
gene editing
genome editing
glioblastoma
hunter syndrome
ids
jeff jonas
loxo oncology
What
phase
4
×
therapeutics
4
×
drug
fda
medicine
new
results
trial
aldeyra
approval
benefit
biotech
black
brexanalone
cancer
clinic
closer
companies
data
depression
diamond
disclosed
editing
eluded
eye
fighting
filing
gene
going
hits
hopes
hour
humans
inflammation
infusion
ipo
isn't
landmark
lead
leading
Language
unset
Current search:
phase
×
therapeutics
×
" life sciences "
×
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges